MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
TCR2 Therapeutics Inc. (NASDAQ:TCRR)
Organization & Developments: TCR2 Therapeutics
Parents
TCR2 Therapeutics Inc. (NASDAQ:TCRR)
Children
2021: Our Take On TCR2 Therapeutics
2021: TCR2 Therapeutics: Trading Near Cash Value
2023: TCR² removed 20% of staff over summer, paving way for latest layoffs
Clinical-stage cell therapy company with a pipeline of novel T cell therapies for patients suffering from cancer
Jumps
*Key People: TCR2 Therapeutics
Finance & Acquisitions: TCR2 Therapeutics